I am delighted to announce that AorTech has completed the acquisition of RUA Medical and David Richmond has become not only the new Group CEO but largest individual shareholder.
RUA Medical is a subcontract medical device developer and manufacturer and is unique in its chosen area of expertise by offering a truly end to end service.
It is intended to re-brand all Group businesses under the RUA banner to help build upon RUA’s first class reputation in the global devices industry.
Bill Brown, Chairman
AorTech is focused on the commercialization of its world leading biomedical polymer technology, components and medical devices.
LICENSE AND SUPPLY
AorTech has, through a licence and supply agreement, all of its materials manufactured by Biomerics, a leading contract manufacturer and innovative polymer solutions provider in the USA.
Building on the success of the Elast-Eon™ polymers Elast-Eon™ Carbonate Silicone (ECSil™) is a family of next generation biomedical polymers.
Elast-Eon™ polymers are now widely accepted as being the most biostable of all polyurethane materials and as such are being used in long term implantation.